Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

John T O'Brien, Alistair Burns, BAP Dementia Consensus Group, Peter Passmore

Research output: Contribution to journalArticlepeer-review

139 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology'. Together they form a unique fingerprint.

Medicine & Life Sciences